New research aims to get closer to settling the fierce debate over whether GLP-1s are worth the cost NBC NewsPilot program to provide cheaper GLP-1 via Medicare stokes shortage fears The GuardianNearly Four Million Medicare Beneficiaries Met the Eligibility Criteria in 2023 for the Medicare GLP-1 Bridge KFFMedicare to Cover Obesity Drugs: Implications for Novo Nordisk and Eli Lilly – Trough Earnings Signal dars.gov.etEli Lilly Stock (LLY) Opinions on Medicare Coverage and Drug Pipeline Advancements Quiver Quantitative
